Forman v. Meridian Bioscience, Inc.

Procedural entryThis page is a short order in Forman v. Meridian Bioscience, Inc.. Read the opinion of the Court — 387 F. Supp. 3d 791
District Court, S.D. Ohio·Decided March 17, 2020·No. 1:17-cv-00774·Unknown

Opinion

IN THE UNITED STATES DISTRICT COURT FOR THE SOUTHERN DISTRICT OF OHIO WESTERN DIVISION

BARBARA FORMAN, Individually and : On Behalf of All Others Similarly : Case No. 1:17-cv-774 Situated, : : Plaintiff, : Judge Susan J. Dlott : v. : : Order Granting Final Approval of MERIDIAN BIOSCIENCE, INC., et al., : Settlement : Defendants. :

This matter came before the Court for a Fairness Hearing on March 16, 2020 pursuant to the Order of this Court entered on October 9, 2019 (“Preliminary Approval Order”) and on the application of the Parties for approval of the Settlement set forth in the Amended Stipulation and Agreement of Settlement (the “Stipulation”), executed as of October 7, 2019 and filed with the Court on that date. All capitalized terms used herein have the meanings set forth and defined in the Stipulation. The Court issues this Final Approval of Settlement only after due consideration of the following documents: (1) Amended Stipulation of Settlement dated October 7, 2019 (Doc. 56-2 at PageID 995–1030); (2) Plan of Allocation set forth in the long-form Notice of Proposed Class Action Settlement (Doc. 56-2 at PageID 1056–1067); (3) Affidavit of Scott Hakala, Ph.D (Doc. 56-3); (4) Order Granting Preliminary Approval of Settlement and Directing Dissemination of Notice to Settlement Class (Doc. 58); (5) Lead Plaintiff’s Motion for Final Approval of Class Action Settlement, Class Certification and Plan of Allocation (Docs. 61, 61-1); (6) Counsel’s Motion for an Award of Attorneys’ Fees and Reimbursement of Litigation Expenses and a Contribution Award (Docs. 62, 62-1); (7) Declaration of Sebastiano Tornatore (Doc. 63); (8) Supplemental Declaration of Sebastiano Tornatore (Doc. 65); (9) [Second] Supplemental Declaration of Eric Schachter (Doc. 65-1); (10) Final Fairness Hearing Presentation (Doc. 66-1); and (11) other supporting documents. The Court has received declarations attesting to the mailing of the Notice, publication of the Summary Notice, and compliance with 28 U.S.C. § 1715 in accordance with the Preliminary

Approval Order. Due and adequate notice having thus been given to the Settlement Class as required by the Preliminary Approval Order, and the Court having considered all papers filed and proceedings in this Action and otherwise being fully informed of the matters herein, and good cause appearing therefore, THE COURT HEREBY ORDERS, ADJUDGES AND DECREES as follows: 1. This Court has jurisdiction over the subject matter of this Action, including the terms and conditions of the Stipulation and all exhibits thereto and the Plan of Allocation of the Net Settlement Fund, and over all Parties to the Action and all Settlement Class Members. 2. Pursuant to Rule 23 of the Federal Rules of Civil Procedure, the Court certifies,

solely for the purposes of effectuating the Settlement, a Settlement Class consisting of all Persons who purchased or otherwise acquired Meridian Bioscience, Inc. (“Meridian”) securities on the open market between March 24, 2016 and October 23, 2017, inclusive, and who were damaged thereby, including the Class Representative (defined in paragraph 3 below). Excluded from the Settlement Class are Defendants; members of the Individual Defendants’ immediate families; officers, directors, and subsidiaries of Meridian; any firm, entity, or corporation wholly owned by any Defendant and/or any member(s) of an Individual Defendant’s immediate family; any trust of which a Defendant is the settlor or which is for his or her benefit and/or that of any member of his or her immediate family; and the legal representatives, heirs, or successors-in- interest of the Defendants. Also excluded from the Settlement Class is the sole person who timely and validly requested exclusion from the Settlement Class in accordance with the instructions provided in the Notice: David Lutzewitz, Exclusion ID 69148567. 3. Pursuant to Rule 23 of the Federal Rules of Civil Procedure, and for purposes of the Settlement only, Lead Plaintiff Barbara Forman is appointed as the class representative for

the Settlement Class (“Class Representative”) and Lead Counsel Levi & Korsinsky, LLP is appointed as counsel for the Settlement Class. 4. The Court finds, for purposes of effectuating the Settlement only, that the prerequisites for a class action under Rules 23(a) and 23(b)(3) of the Federal Rules of Civil Procedure have been satisfied in that: (a) the Settlement Class Members are so numerous that joinder of all Settlement Class Members in the Action is impracticable; (b) there are questions of law and fact common to the Settlement Class which predominate over any individual questions; (c) the claims of the Court-appointed Class Representative is typical of the claims of the Settlement Class she represents; (d) Class Representative and Lead Counsel have fairly and

adequately represented and protected the interests of all Settlement Class Members and will continue to do so; and (e) a class action is superior to other available methods for the fair and efficient adjudication of the controversy, considering: (i) the interests of Settlement Class Members in individually controlling the prosecution of separate actions; (ii) the extent and nature of any litigation concerning the controversy already commenced by Settlement Class Members; (iii) the desirability or undesirability of continuing the Action in this particular forum; and (iv) the likely difficulties in managing the Action. Accordingly, pursuant to Rule 23 of the Federal Rules of Civil Procedure, the Court certifies the Settlement Class, solely for the purposes of effectuating this Settlement. 5. This Court finds that the distribution of the Notice and the publication of the Summary Notice, and the form and methodology of notice, all implemented in accordance with the terms of the Stipulation and the Court’s Preliminary Approval Order: (a) constituted the best practicable notice to Settlement Class Members under the circumstances;

(b) were reasonably calculated, under the circumstances, to apprise Settlement Class Members of: (i) the nature of the action; (ii) the definition of the Class to be certified; (iii) the class claims, issues, and Defendants’ defenses; (iv) the terms and effect of the Stipulation and the proposed Settlement of this Action; (v) their right to exclude themselves from the Settlement Class; (vi) their right to object to any aspect of the proposed Settlement; (vii) their right to appear at the Final Approval Hearing, either on their own or through counsel hired at their own expense, if they did not exclude themselves from the Settlement Class; and (viii) the binding effect of the proceedings, rulings, orders, and judgments in this Action, whether favorable or unfavorable, on all

Persons who are not excluded from the Settlement Class; (c) were reasonable and constituted due, adequate, and sufficient notice to all Persons entitled to be provided with notice; and (d) fully satisfied all applicable requirements of the Federal Rules of Civil Procedure

Free access — add to your briefcase to read the full text and ask questions with AI

Forman v. Meridian Bioscience, Inc., (S.D. Ohio 2020).

Forman v. Meridian Bioscience, Inc. (Forman v. Meridian Bioscience, Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related